53 related articles for article (PubMed ID: 2312602)
1. Discovery of Pharmaceutical Composition for Prevention and Treatment in Patient-Derived Metastatic Medullary Thyroid Carcinoma Model.
Yun HJ; Lim JH; Kim SY; Kim SM; Park KC
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009450
[TBL] [Abstract][Full Text] [Related]
2. Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors.
Wells SA
Endocr Relat Cancer; 2018 Feb; 25(2):T1-T13. PubMed ID: 29142004
[TBL] [Abstract][Full Text] [Related]
3. Uncommon response of cisplatin and etoposide for treatment of advanced medullary thyroid carcinoma.
Panomuppakarn N; Witoonpanich P; Waisayarat J; Jiarpinitnun C; Ativitavas T; Ngamphaiboon N
Clin Case Rep; 2017 Oct; 5(10):1628-1633. PubMed ID: 29026560
[TBL] [Abstract][Full Text] [Related]
4. A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers.
Halperin DM; Phan AT; Hoff AO; Aaron M; Yao JC; Hoff PM
BMC Cancer; 2014 Aug; 14():561. PubMed ID: 25086465
[TBL] [Abstract][Full Text] [Related]
5. Medical management of metastatic medullary thyroid cancer.
Maxwell JE; Sherman SK; O'Dorisio TM; Howe JR
Cancer; 2014 Nov; 120(21):3287-301. PubMed ID: 24942936
[TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.
Wells SA; Pacini F; Robinson BG; Santoro M
J Clin Endocrinol Metab; 2013 Aug; 98(8):3149-64. PubMed ID: 23744408
[TBL] [Abstract][Full Text] [Related]
7. Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.
Giunti S; Antonelli A; Amorosi A; Santarpia L
Int J Endocrinol; 2013; 2013():803171. PubMed ID: 23509459
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer.
Deshpande H; Marler V; Sosa JA
Onco Targets Ther; 2011; 4():209-15. PubMed ID: 22241953
[TBL] [Abstract][Full Text] [Related]
9. Thyroid cancer: emerging role for targeted therapies.
Sipos JA; Shah MH
Ther Adv Med Oncol; 2010 Jan; 2(1):3-16. PubMed ID: 21789122
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer.
Argiris A; Agarwala SS; Karamouzis MV; Burmeister LA; Carty SE
Invest New Drugs; 2008 Apr; 26(2):183-8. PubMed ID: 17909728
[TBL] [Abstract][Full Text] [Related]
11. Medullary thyroid cancer: medical management and follow-up.
Traugott A; Moley JF
Curr Treat Options Oncol; 2005 Jul; 6(4):339-46. PubMed ID: 15967086
[TBL] [Abstract][Full Text] [Related]
12. Medullary thyroid carcinoma.
Moley JF
Curr Treat Options Oncol; 2003 Aug; 4(4):339-47. PubMed ID: 12943614
[TBL] [Abstract][Full Text] [Related]
13. [Drug therapy of endocrine neoplasms. Part I: Thyroid neoplasms, adrenal neoplasms and parathyroid neoplasms].
Schott M; Scherbaum WA; Feldkamp J
Med Klin (Munich); 2000 Jan; 95(1):20-5. PubMed ID: 10668340
[TBL] [Abstract][Full Text] [Related]
14. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection.
Moley JF; DeBenedetti MK
Ann Surg; 1999 Jun; 229(6):880-7; discussion 887-8. PubMed ID: 10363903
[TBL] [Abstract][Full Text] [Related]
15. Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection.
Chen H; Roberts JR; Ball DW; Eisele DW; Baylin SB; Udelsman R; Bulkley GB
Ann Surg; 1998 Jun; 227(6):887-95. PubMed ID: 9637552
[TBL] [Abstract][Full Text] [Related]
16. [Progress in the diagnosis and therapy of C cell carcinoma of the thyroid gland].
Frilling A; Goretzki PE; Röher HD
Langenbecks Arch Chir; 1990; 375(6):333-9. PubMed ID: 2280648
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study.
Scherübl H; Raue F; Ziegler R
J Cancer Res Clin Oncol; 1990; 116(1):21-3. PubMed ID: 2312602
[TBL] [Abstract][Full Text] [Related]
18. [Combination therapy with adriamycin, cisplatin and vindesine in C cell carcinoma of the thyroid].
Scherübl H; Raue F; Ziegler R
Onkologie; 1990 Jun; 13(3):198-202. PubMed ID: 2204006
[TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial.
Williams SD; Birch R; Einhorn LH
Cancer Treat Rep; 1986 Mar; 70(3):405-7. PubMed ID: 3955552
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
